Shigetoshi Sano

Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model

Shigetoshi Sano, Keith Syson Chan, Steve Carbajal et al. · Nature Medicine · 2004 · 747 citations

Medicine, Cell Biology, Dermatology +14

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Youn H. Kim, M. Bagot, Lauren Pinter‐Brown et al. · The Lancet Oncology · 2018 · 645 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Keratinocyte‐specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis

Shigetoshi Sano, Satoshi Itami, Masahito Tarutani et al. · The EMBO Journal · 1999 · 518 citations · Full text

Life Sciences, Genetics, Molecular Genetics +11

A novel reporter mouse strain that expresses enhanced green fluorescent protein upon Cre‐mediated recombination

Shunsuke Kawamoto, Hitoshi Niwa, Fumi Tashiro et al. · FEBS Letters · 2000 · 356 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis

Keith Syson Chan, Shigetoshi Sano, Kaoru Kiguchi et al. · Journal of Clinical Investigation · 2004 · 314 citations

Medicine, Dermatology, Oncology +17